| Geriatrics | 卷:5 |
| The Clinical Frailty Scale: Estimating the Prevalence of Frailty in Older Patients Hospitalised with COVID-19. The COPE Study | |
| Arturo Vilches-Moraga1  Ben Carter2  Roxanna Short3  JemimaT. Collins4  MichaelJ. Stechman5  Susan Moug6  Kathryn McCarthy7  Jonathan Hewitt8  PhyoK. Myint9  TerenceJ. Quinn10  Alessia Verduri11  | |
| [1] Ageing and Complex Medicine Department, Salford Royal NHS Trust, University of Manchester, Manchester M6 8HD, UK; | |
| [2] Department of Biostatistics and Health Informatics, King’s College London, London SE5 8AF, UK; | |
| [3] Department of Forensic and Neurodevelopmental Sciences, King’s College London, London SE5 8AF, UK; | |
| [4] Department of Geriatric Medicine, Aneurin Bevan UHB, Caerphilly CF82 7GP, UK; | |
| [5] Department of Surgery, Cardiff and Vale UHB, Cardiff CF14 4XW, UK; | |
| [6] Department of Surgery, Royal Alexandra Hospital, Paisley PA2 9PN, UK; | |
| [7] Department of Surgery, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK; | |
| [8] Division of Population Medicine, Aneurin Bevan UHB, Cardiff University, Cardiff CF14 4XN, UK; | |
| [9] Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK; | |
| [10] Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK; | |
| [11] Respiratory Unit, Hospital Policlinico, University of Modena and Reggio Emilia, 41121 Modena, Italy; | |
| 关键词: frailty; Clinical Frailty Scale; COVID-19; prevalence; hospital; | |
| DOI : 10.3390/geriatrics5030058 | |
| 来源: DOAJ | |
【 摘 要 】
Frailty assessed using Clinical Frailty Scale (CFS) is a good predictor of adverse clinical events including mortality in older people. CFS is also an essential criterion for determining ceilings of care in people with COVID-19. Our aims were to assess the prevalence of frailty in older patients hospitalised with COVID-19, their sex and age distribution, and the completion rate of the CFS tool in evaluating frailty. Methods: Data were collected from thirteen sites. CFS was assessed routinely at the time of admission to hospital and ranged from 1 (very fit) to 9 (terminally ill). The completion rate of the CFS was assessed. The presence of major comorbidities such as diabetes and cardiovascular disease was noted. Results: A total of 1277 older patients with COVID-19, aged ≥ 65 (79.9 ± 8.1) years were included in the study, with 98.5% having fully completed CFS. The total prevalence of frailty (CFS ≥ 5) was 66.9%, being higher in women than men (75.2% vs. 59.4%, p < 0.001). Frailty was found in 161 (44%) patients aged 65–74 years, 352 (69%) in 75–84 years, and 341 (85%) in ≥85 years groups, and increased across the age groups (<0.0001, test for trend). Conclusion: Frailty was prevalent in our cohort of older people admitted to hospital with COVID-19. This indicates that older people who are also frail, who go on to contract COVID-19 may have disease severity significant enough to warrant hospitalization. These data may help inform health care planners and targeted interventions and appropriate management for the frail older person.
【 授权许可】
Unknown